Global equity markets remained volatile throughout the month due to news surrounding re-opening of economies, upward moving Treasury rates, fears of new COVID-19 waves and political/medical interfering with AstraZeneca’s vaccine. The MSCI World Healthcare NR Index gained 2.5% in March, while the MSCI World NR Index rose 3.3%.
What do you think, how many people still take their prescribed drugs after 12? Actually, the numbers are quite scary and vary significantly by the type of the disease. Watch the video to find out more.
Will they/Won’t they? The Jackson Hole meeting at the end of August and the question around slowing the pace of bond purchases spooked the market throughout the whole month (next to the Delta-variant). In such times of uncertainties Healthcare (2.8%) did what it is supposed to do: it outperformed the market (2.5%). Year to date, Healthcare (17.2%) trades now almost on par with the global markets (17.9%)